CAR T Cell Therapy

Cardio-oncological evaluation* AND Troponin, NT-proBNP

before cancer treatment begins

ECG AND Troponin AND NT-proBNP

at Day 7 after CAR T Cell infusion AND

if cardiovascular symptoms/signs AND 

if cytokine release syndrome occurs

* A cardio-oncological evaluation will systematically include at least one visit with blood pressure, blood glucose, lipid profile, GFR calculation, ECG and trans-thoracic echocardiography (TTE). Measurements of global longitudinal strain and 3D LVEF (if feasible) are recommended with the same machine.